NEW YORK--(BUSINESS WIRE)--Synergy Pharmaceuticals, Inc. (OTCBB: SGYP), a developer of new drugs to treat gastrointestinal (GI) disorders and diseases, today announced that Dr. Gary S. Jacob, the company's president and chief executive officer, is scheduled to present at the 13th Annual BIO CEO and Investor Conference at 1:30 pm ET on February 14, 2011 at the Waldorf Astoria Hotel in New York City.
